Indoco Remedies Achieves EU GMP Certification for Manufacturing Facility in Baddi
Indoco Remedies receives EU GMP certification from Malta Medicines Authority
Business Standard
Image: Business Standard
Indoco Remedies has received EU Good Manufacturing Practice (GMP) certification for its solid oral dosage manufacturing facility located in Baddi, Himachal Pradesh, India, following an inspection by the Malta Medicines Authority from January 29 to February 3, 2026. This certification confirms compliance with EU manufacturing standards.
- 01Indoco Remedies' facility in Baddi has received EU GMP certification.
- 02The inspection was conducted by the Malta Medicines Authority.
- 03The certification confirms compliance with EU manufacturing standards.
- 04The inspection took place from January 29 to February 3, 2026.
- 05This certification enhances the company's credibility in the European market.
Advertisement
In-Article Ad
Indoco Remedies, a pharmaceutical company, has successfully obtained EU Good Manufacturing Practice (GMP) certification for its manufacturing facility located in Baddi, Himachal Pradesh, India. The certification follows an inspection conducted by the Malta Medicines Authority from January 29 to February 3, 2026. This certification confirms that the facility adheres to the stringent manufacturing standards outlined in the European Community Directive. Achieving EU GMP certification not only validates the quality of Indoco's manufacturing processes but also strengthens its position in the European pharmaceutical market, potentially opening up new business opportunities.
Advertisement
In-Article Ad
The certification may lead to increased business opportunities for Indoco Remedies in the European market, which can positively affect local employment and economic growth.
Advertisement
In-Article Ad
Reader Poll
How important is EU GMP certification for Indian pharmaceutical companies?
Connecting to poll...
More about Indoco Remedies
Read the original article
Visit the source for the complete story.